ClinicalTrials.gg
Enrolling by invitationNCT07943481Updated Nov 17, 2026

Can we Teach Novice Doctors to Better Handle Uncertainty in Clinical Practice Using Adaptive Expertise and Simulation?

An interventional study of Reflective cases and BAEP-guided observation and debriefing and Direct instruction and TeamGAINS debriefing in Clinical Decision-making Under Uncertainty, sponsored by University of Aarhus. Enrolling by invitation at 1 site in Denmark. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of Aarhus · Not applicable, Interventional, and Other

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Sex
All
01

Study summary

This study explores how two simulation-based educational approaches support junior doctors in making clinical decisions when information is uncertain or incomplete. Both groups attend a one-day course with teaching on adaptive expertise and practice in simulated clinical scenarios.

The intervention group works with reflective cases, uses observation sheets focused on adaptive expert behaviour, and takes part in debriefing guided by the Behavioral Framework for Adaptive Expert Performance (BAEP). The comparison group receives instructor-led case teaching, uses open observation sheets that may draw on scenario learning objectives, and takes part in TeamGAINS debriefing.

Two course days are held each semester, with 16 participants per day. Within each semester, one day is randomly allocated to each approach. Participants are not informed whether their course day is assigned to the intervention or comparison group.

The study examines adaptive behaviour in simulation, participants' experiences discussed during debriefing, and changes in general self-efficacy and reactions to uncertainty. The qualitative BAEP analysis includes simulation recordings from the first four course days in autumn 2026 and spring 2027, with approximately 64 participants. Questionnaire and debriefing data are collected across eight course days, provisionally through spring 2028, with an anticipated total of 128 participants. Questionnaires are completed before and immediately after the course and three months later. The study compares the complete educational approaches rather than the isolated effect of any single component.

Read the detailed description

Background and purpose Clinical decisions often have to be made with incomplete information and uncertain diagnoses. Adaptive expertise involves recognising uncertainty, reconsidering an initial interpretation, and adjusting decisions and actions as a situation develops. Simulation provides an opportunity to explore these processes in clinical scenarios without exposing patients to the consequences of participants' decisions.

This study compares two educational approaches embedded in a one-day simulation course for junior doctors. It explores how adaptive behaviour is expressed during simulation, how participants describe their experiences and reasoning during debriefing, and how self-efficacy and reactions to uncertainty change over time. The comparison concerns the combined educational approaches, including case teaching, observation guidance and debriefing.

Design and allocation The study uses a parallel-group design with randomisation at the course-day level. Two course days, each with 16 participants, are delivered per semester. Within each semester, one course day is randomly allocated to the intervention and the other to the active comparator. Participants on a given course day receive the same educational approach. Both groups receive teaching on adaptive expertise and clinical decision-making and undertake four simulation scenarios, organised in teams of four.

Participants are not informed of their intervention or comparator allocation. Investigators analysing the video recordings know the allocation. Analyses and interpretation take account of the course-day allocation and team context.

Educational approaches In the intervention group, participants work in pairs with reflective clinical cases before simulation. While observing scenarios, they use a BAEP-related observation sheet. Debriefing is guided by BAEP and explores how physicians question their initial understanding, use and reassess knowledge, and adapt their actions when new information emerges or a plan does not work as expected. Discussion includes alternative actions and participants' learning points.

In the active comparator group, participants receive conventional instructor-led case teaching before simulation. Observers use an open notes sheet and may draw on the scenario learning objectives. Scenarios are followed by TeamGAINS debriefing addressing clinical and team performance and transfer of learning to practice.

Data collection and analysis Qualitative analysis of simulation recordings uses BAEP as an analytical framework. It focuses primarily on individual physicians' adaptive behaviour, including how they recognise uncertainty, reconsider their understanding, and modify decisions and actions through interaction with the team. It is not based on a total performance score or counts of behaviour. Patterns are explored within and across the educational groups. This analysis is restricted to recordings from the first four course days in autumn 2026 and spring 2027, involving approximately 64 participants, and will take place after the spring 2027 courses.

Questionnaire and video-recorded debriefing data are collected across eight course days, provisionally extending through spring 2028, with an anticipated total enrolment of 128 participants. The first approximately 64 participants are included in this total. Enrolment is based on planned course capacity, rather than a formal statistical power calculation.

Questionnaires are administered electronically via REDCap before the course, immediately afterwards and at three-month follow-up. General self-efficacy is assessed using the Danish General Self-Efficacy Scale. Reactions to uncertainty are assessed using the 15-item Danish Physicians' Reactions to Uncertainty questionnaire (PRU-DK), using item 9a and not item 9b. The four subscales are scored separately according to the scoring instructions. Items 4, 9a, 10 and 12 are reverse-scored, and a subscale is not scored if an item response is missing. Follow-up assesses self-reported self-efficacy and reactions to uncertainty, not observed adaptive performance.

Video-recorded debriefing discussions are analysed qualitatively using thematic analysis to explore participants' experiences and reasoning during simulation. The analysis includes the physician acting as decision-maker and contributions from other team members. Interpretation takes account of the different debriefing approaches and prompts used in the two groups, since debriefing is itself part of the educational intervention.

The primary data collection ends with the fourth course day in spring 2027. Collection of secondary outcomes continues through the final three-month questionnaire follow-up after the spring 2028 courses. Findings will inform further development of the course.

02

Conditions studied

  • Clinical Decision-making Under Uncertainty

Keywords

  • Adaptive expertise
  • Medical education
  • Productive failure
  • simulation
  • clinical decision making
03

In context

Lead sponsor

University of Aarhus is the lead sponsor of 1,301 studies on the registry; 189 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Junior doctors currently in KBU, introductory course or in the first year of main education

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
128 participants (estimated)

Study arms

  • Active comparator
    Direct instruction and TeamGAINS debriefing

    Participants receive teaching on adaptive expertise and conventional instructor-led clinical case teaching, followed by four simulation scenarios. While observing scenarios, participants use an open notes sheet and may draw on the scenario learning objectives. Each scenario is followed by TeamGAINS debriefing addressing clinical and team performance and transfer of learning to practice.

    Behavioral: Direct instruction and TeamGAINS debriefing

  • Experimental
    Reflective cases and BAEP-guided observation and debriefing

    Participants receive teaching on adaptive expertise and work in pairs with reflective clinical cases before completing four simulation scenarios. While observing scenarios, they use a BAEP-related observation sheet. Each scenario is followed by BAEP-guided debriefing exploring uncertainty, reconsideration of initial interpretations, use of knowledge, and adaptation of decisions and actions. The intervention is the combined package of reflective cases, structured observation guidance and BAEP debriefing.

    Behavioral: Reflective cases and BAEP-guided observation and debriefing

Interventions

  • BehavioralReflective cases and BAEP-guided observation and debriefing

    Junior doctors work in pairs on reflective clinical cases before simulation. They use a BAEP-related observation sheet while observing scenarios. After each scenario, BAEP-guided debriefing examines how doctors reconsider initial interpretations and adapt decisions as information changes. The course also includes shared teaching on adaptive expertise and simulation practice.

  • BehavioralDirect instruction and TeamGAINS debriefing

    Junior doctors receive conventional instructor-led case teaching before simulation. Observers use an open notes sheet and may draw on the scenario learning objectives. Each scenario is followed by TeamGAINS debriefing on clinical and team performance and transfer to practice. The course also includes shared teaching on adaptive expertise and simulation practice.

06

What researchers measure

Primary outcomes

  1. Adaptive expert behavior in simulated clinical scenarios

    Qualitative analysis of video-recorded simulation scenarios using the Behavioral Framework for Adaptive Expert Performance (BAEP) as an analytical framework. The analysis focuses on how individual physicians recognise uncertainty, reconsider their initial understanding, and adapt clinical decisions and actions, including through interaction with the team. Patterns are explored within and across the two educational groups, rather than expressed as a total score or counts of behaviour. The analysis is restricted to the first four course days in autumn 2026 and spring 2027 (approximately 64 participants). Investigators analysing the recordings know the group allocation.

    Time frame: During the four simulation scenarios on the course day; assessed in participants from the first four course days (autumn 2026 to spring 2027).

Secondary outcomes

  1. General self-efficacy

    Danish version of the General Self-Efficacy Scale (GSE), 10 items, 4-point Likert scale, total score 10-40 (higher = stronger belief in one's ability to act). Administered electronically. Reported as change from baseline.

    Time frame: Baseline, immediately after the course, and 3 months after the course

  2. Physicians' reactions to uncertainty

    Danish Physicians' Reactions to Uncertainty questionnaire (PRU-DK), 15 items scored from 1 to 6, using item 9a and excluding item 9b. Four subscales are reported separately: anxiety due to uncertainty (5-30), concern about bad outcomes (3-18), reluctance to disclose uncertainty to patients (5-30), and reluctance to disclose mistakes to physicians (2-12). Items 4, 9a, 10 and 12 are reverse-scored. Higher subscale scores indicate greater anxiety, concern or reluctance, respectively. A subscale is not scored if an item response is missing. Changes from baseline are assessed for each subscale; no combined total score is used. Data are collected across all eight planned course days.

    Time frame: Baseline, immediately after the course, and 3 months after the course

  3. Participants' experience in simulation

    Qualitative thematic analysis of video-recorded debriefing discussions following the simulation scenarios, exploring participants' experiences and clinical reasoning. The analysis includes the physician acting as decision-maker and contributions from other team members. Data are collected across all eight planned course days, provisionally through spring 2028. The intervention group receives BAEP-guided debriefing and the active comparator receives TeamGAINS debriefing. Interpretation of similarities and differences takes account of the different facilitation approaches and prompts, since debriefing is also part of the educational intervention.

    Time frame: Immediately after each simulation scenario (same day)

07

Study locations

1 site
  • Corporate HR, MidtSim
    Aarhus C, Central Jutland 8000, Denmark
08

References and documents

Individual participant data

Plan to share: No — There is currently no plan to share individual participant data with other researchers.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2026 (actual). Primary completion is estimated for Mar 2027, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 21, 2026
First posted
Nov 17, 2026
StartActual
Oct 23, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Jun 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943481
Collaborators
Central Denmark Region
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Oct 23, 2026
Primary completion
Mar 2027 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion